The Role of Human LRRK2 in Methylmercury-Induced Inhibition of Microvesicle Formation of Cephalic Neurons in Caenorhabditis elegans.


Journal

Neurotoxicity research
ISSN: 1476-3524
Titre abrégé: Neurotox Res
Pays: United States
ID NLM: 100929017

Informations de publication

Date de publication:
Oct 2020
Historique:
received: 13 06 2020
accepted: 22 07 2020
revised: 21 07 2020
pubmed: 30 7 2020
medline: 10 7 2021
entrez: 30 7 2020
Statut: ppublish

Résumé

In a previous study, we have shown that methylmercury (MeHg) exposure causes focal aggregation of intracellular transgenic mCherry protein in dendrites of cephalic (CEP) neurons in Caenorhabditis elegans (C. elegans). However, the underlying mechanism is unknown. We hypothesized that reduced cellular release of mCherry via extracellular vesicles by MeHg contributes to its accumulation and intracellular aggregation. Thus, we characterized vesicular structures in CEP dendrites, which were 1-3 μm in diameter and could readily bud off from the plasma membrane of the dendrites. Chronic treatment of C. elegans with MeHg (5 μM, 4-10 days) reduced the number of vesicles attached to CEP dendrites (attached vesicles) and vesicles unattached to CEP dendrites (unattached vesicles), as well as the presence of extracellular mCherry, supporting the hypothesis that release of mCherry by microvesicle formation is inhibited by MeHg. Leucine-rich repeat kinase 2 (LRRK2) has an important function in membrane biology. Further investigation showed that the effects of MeHg were modified by human LRRK2. In worms with the wild-type LRRK2, the vesicle numbers were significantly reduced by MeHg (0.5 and 5 μM). The effects of MeHg on the presence of extracellular mCherry and attached vesicles were modified by the human wild-type LRRK2. Independent of MeHg treatment, the G2019S mutant LRRK2 showed reduced number of unattached vesicles; however, the levels of extracellular mCherry were increased. Knockdown of C. elegans irk-1, the homolog of human LRRK2, reduced the number of attached vesicles, corroborating that LRRK2 plays an important role in the formation of microvesicles.

Identifiants

pubmed: 32725544
doi: 10.1007/s12640-020-00262-5
pii: 10.1007/s12640-020-00262-5
pmc: PMC7484354
mid: NIHMS1615867
doi:

Substances chimiques

Methylmercury Compounds 0
LRRK2 protein, human EC 2.7.11.1
Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 EC 2.7.11.1
Protein Serine-Threonine Kinases EC 2.7.11.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

751-764

Subventions

Organisme : NIH HHS
ID : P40 OD010440
Pays : United States
Organisme : NIH HHS
ID : S10 OD023591
Pays : United States
Organisme : NIEHS NIH HHS
ID : ES010563
Pays : United States
Organisme : NIEHS NIH HHS
ID : R01 ES007331
Pays : United States
Organisme : NIEHS NIH HHS
ID : R01 ES010563
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA013330
Pays : United States
Organisme : NIEHS NIH HHS
ID : ES007331
Pays : United States

Références

Curr Biol. 2011 Dec 6;21(23):1951-9
pubmed: 22100064
Front Neurosci. 2019 Dec 17;13:1352
pubmed: 31920513
Chembiochem. 2014 May 5;15(7):923-8
pubmed: 24740901
J Neurosci. 2019 Jul 17;39(29):5760-5772
pubmed: 31097622
Toxicol Appl Pharmacol. 2011 Nov 1;256(3):405-17
pubmed: 21601588
Nat Genet. 2003 Jan;33(1):40-8
pubmed: 12447374
Mol Neurodegener. 2016 Dec 7;11(1):73
pubmed: 27927216
PLoS One. 2014 Jan 21;9(1):e84926
pubmed: 24465451
Nat Neurosci. 2013 Apr;16(4):394-406
pubmed: 23455607
Curr Biol. 2007 Apr 3;17(7):592-8
pubmed: 17346966
Neurotoxicology. 2020 Mar;77:105-113
pubmed: 31935438
Annu Rev Biochem. 2017 Jun 20;86:97-122
pubmed: 28489421
Neurobiol Dis. 2006 Aug;23(2):329-41
pubmed: 16750377
Front Synaptic Neurosci. 2017 Feb 23;9:5
pubmed: 28280464
J Biol Chem. 2009 Jun 12;284(24):16482-91
pubmed: 19251702
Cell Cycle. 2009 Jul 1;8(13):2014-8
pubmed: 19535896
J Extracell Vesicles. 2019 Jun 17;8(1):1626654
pubmed: 31258880
Hum Mol Genet. 2007 Sep 1;16(17):2031-9
pubmed: 17584768
Nat Methods. 2010 Jul;7(7):554-9
pubmed: 20512143
FASEB J. 2016 Jan;30(1):336-47
pubmed: 26396237
WormBook. 2006 Apr 05;:1-23
pubmed: 18050449
Int J Mol Med. 2008 Jan;21(1):63-7
pubmed: 18097617
J Neurosci. 2009 Jul 22;29(29):9210-8
pubmed: 19625511
Cell. 2001 Jul 27;106(2):157-69
pubmed: 11511344
PLoS One. 2019 Jan 15;14(1):e0210248
pubmed: 30645642
Neuron. 2004 Nov 18;44(4):601-7
pubmed: 15541309
Stem Cell Reports. 2019 Feb 12;12(2):213-229
pubmed: 30639209
Hum Mol Genet. 2017 Nov 15;26(22):4340-4351
pubmed: 28973664
Nat Rev Neurol. 2020 Feb;16(2):97-107
pubmed: 31980808
J Comp Neurol. 1975 Apr 1;160(3):313-37
pubmed: 1112927
Nature. 1998 Feb 19;391(6669):806-11
pubmed: 9486653
J Neurosci. 2010 May 19;30(20):6838-51
pubmed: 20484626
Elife. 2014 Mar 25;3:e01948
pubmed: 24668170
Dev Cell. 2017 Nov 20;43(4):403-417.e10
pubmed: 29161591
Mol Neurodegener. 2019 Dec 21;14(1):49
pubmed: 31864390
Sci Signal. 2019 Mar 12;12(572):
pubmed: 30862700
Exp Neurol. 2017 Dec;298(Pt B):236-245
pubmed: 28764903
Development. 2005 Aug;132(15):3357-69
pubmed: 15975936
Curr Biol. 2014 Mar 3;24(5):519-25
pubmed: 24530063
Cell. 1998 Oct 16;95(2):199-210
pubmed: 9790527
Nature. 2017 Feb 16;542(7641):367-371
pubmed: 28178240
Nat Neurosci. 1999 Nov;2(11):959-64
pubmed: 10526333
Cell. 1991 May 31;65(5):837-47
pubmed: 1710172

Auteurs

Tao Ke (T)

Department of Molecular Pharmacology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Forchheimer Building, Room 209, Bronx, NY, 10461, USA.

Abel Santamaria (A)

Laboratorio de Aminoácidos Excitadores, Instituto Nacional de Neurología y Neurocirugía, 14269, Mexico City, Mexico.

Joao B T Rocha (JBT)

Department of Biochemistry and Molecular Biology, Federal University of Santa Maria, Santa Maria, RS, Brazil.

Alexey A Tinkov (AA)

Yaroslavl State University, Sovetskaya St., 14, Yaroslavl, Russia, 150000.
IM Sechenov First Moscow State Medical University, Sechenov University, Moscow, Russia.

Rongzhu Lu (R)

Department of Preventive Medicine and Public Health Laboratory Sciences, School of Medicine, Jiangsu University, Zhenjiang, 212013, Jiangsu, China.

Aaron B Bowman (AB)

School of Health Sciences, Purdue University, West Lafayette, IN, 47907-2051, USA.

Michael Aschner (M)

Department of Molecular Pharmacology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Forchheimer Building, Room 209, Bronx, NY, 10461, USA. michael.aschner@einstein.yu.edu.
IM Sechenov First Moscow State Medical University, Sechenov University, Moscow, Russia. michael.aschner@einstein.yu.edu.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH